32. Autophagic vacuolar myopathy Disease details / Clinical trials / Drug dev / DR info /


Clinical trial : 1 Drug : 1 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countires)
RP-A501
   Rocket Pharmaceuticals Inc.
      2019   Phase 1   NCT03882437   United States;